ATAI Life Sciences N.V (NASDAQ:ATAI) shares, rose in value, with the stock price up by 5.44% to the previous day’s close as strong demand from buyers drove the stock to $1.55.
Actively observing the price movement in the recent trading, the stock is buoying the session at $1.47, falling within a range of $1.45 and $1.58. The value of beta (5-year monthly) is 1.186. Referring to stock’s 52-week performance, its high was $2.85, and the low was $1.03. On the whole, ATAI has fluctuated by -10.40% over the past month.
With the market capitalization of ATAI Life Sciences N.V currently standing at about $307.37 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-16.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ATAI’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of ATAI currently trading nearly 4.04% and -9.15% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 48.88, while the 7-day volatility ratio is showing 9.74% which for the 30-day chart, stands at 8.96%. Furthermore, ATAI Life Sciences N.V (ATAI)’s beta value is 1.21, and its average true range (ATR) is 0.15.
A comparison of ATAI Life Sciences N.V (ATAI) with its peers suggests the former has fared considerably weaker in the market. ATAI showed an intraday change of 5.44% in today’s session so far, and over the past year, it shrunk by -6.63%%.
Data on historical trading for ATAI Life Sciences N.V (NASDAQ:ATAI) indicates that the trading volumes over the past 10 days have averaged 1.65 and over the past 3 months, they’ve averaged 2.89 million. According to company’s latest data on outstanding shares, there are 167.82 million shares outstanding.
Nearly 32.31% of ATAI Life Sciences N.V’s shares belong to company insiders and institutional investors own 7.34% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 10.4 million shares as on 2025-03-14, resulting in a short ratio of 3.61. According to the data, the short interest in ATAI Life Sciences N.V (ATAI) stood at 656.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 11.16 million. The stock has risen by 16.54% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ATAI stock heading into the next quarter.
